| Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma KJ Yong, C Gao, JSJ Lim, B Yan, H Yang, T Dimitrov, A Kawasaki, ... New England Journal of Medicine 368 (24), 2266-2276, 2013 | 274 | 2013 |
| A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma THM Chan, CH Lin, L Qi, J Fei, Y Li, KJ Yong, M Liu, Y Song, RKK Chow, ... Gut 63 (5), 832-843, 2014 | 234 | 2014 |
| SALL4 is a new target in endometrial cancer A Li, Y Jiao, KJ Yong, F Wang, C Gao, B Yan, S Srivastava, GSD Lim, ... Oncogene 34 (1), 63-72, 2015 | 114 | 2015 |
| Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex C Gao, T Dimitrov, KJ Yong, H Tatetsu, H Jeong, HR Luo, JE Bradner, ... Blood, The Journal of the American Society of Hematology 121 (8), 1413-1421, 2013 | 84 | 2013 |
| Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression KJ Yong, DS Basseres, RS Welner, WC Zhang, H Yang, B Yan, ... Science translational medicine 8 (350), 350ra104-350ra104, 2016 | 60 | 2016 |
| New high-throughput screening identifies compounds that reduce viability specifically in liver cancer cells that express high levels of SALL4 by inhibiting oxidative … JL Tan, F Li, JZ Yeo, KJ Yong, MA Bassal, GH Ng, MY Lee, CY Leong, ... Gastroenterology 157 (6), 1615-1629. e17, 2019 | 59 | 2019 |
| Zinc finger protein SALL4 functions through an AT-rich motif to regulate gene expression NR Kong, MA Bassal, HK Tan, JV Kurland, KJ Yong, JJ Young, Y Yang, ... Cell reports 34 (1), 2021 | 47 | 2021 |
| Clinical and therapeutic relevance of PIM1 kinase in gastric cancer B Yan, EX Yau, S Samanta, CW Ong, KJ Yong, LK Ng, B Bhattacharya, ... Gastric Cancer 15, 188-197, 2012 | 44 | 2012 |
| Targeting SALL4 by entinostat in lung cancer KJ Yong, A Li, WB Ou, CKY Hong, W Zhao, F Wang, H Tatetsu, B Yan, ... Oncotarget 7 (46), 75425, 2016 | 37 | 2016 |
| Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 … B Yan, EX Yau, SN Choo, CW Ong, KJ Yong, B Pang, M Salto-Tellez Journal of clinical pathology 64 (10), 880-883, 2011 | 37 | 2011 |
| Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation enables accurate assessment of HER2 genomic status in ovarian tumours B Yan, SN Choo, P Mulyadi, S Srivastava, CW Ong, KJ Yong, T Putti, ... Journal of clinical pathology 64 (12), 1097-1101, 2011 | 35 | 2011 |
| Identification of MET genomic amplification, protein expression and alternative splice isoforms in neuroblastomas B Yan, M Lim, L Zhou, CH Kuick, MY Leong, KJ Yong, LL Aung, ... Journal of Clinical Pathology 66 (11), 985-991, 2013 | 20 | 2013 |
| ChIP-AP: an integrated analysis pipeline for unbiased ChIP-seq analysis J Suryatenggara, KJ Yong, DE Tenen, DG Tenen, MA Bassal Briefings in Bioinformatics 23 (1), bbab537, 2022 | 11 | 2022 |
| The relevance of symmetric and asymmetric cell divisions to human central nervous system diseases KJ Yong, B Yan Journal of Clinical Neuroscience 18 (4), 458-463, 2011 | 8 | 2011 |
| Spalt-like transcription factor 4 (SALL4) and uses thereof L Chai, T Dimitrov, DG Tenen, KJ Yong, BH Liu US Patent 9,365,851, 2016 | 5 | 2016 |
| A novel JAK2 R564* variant in a patient with thrombocytosis. A Villanueva, KS Poon, CA Gallardo, CN Chai, L Chiu, B Yan, CSL Ding, ... International Journal of Laboratory Hematology 42 (2), 2020 | 1 | 2020 |
| ChIP-AP–An Integrated ChIP-Seq Analysis Pipeline J Suryatenggara, KJ Yong, DE Tenen, DG Tenen, MA Bassal bioRxiv, 2021.04. 18.440382, 2021 | | 2021 |
| A high-throughput chemical genetic screen reveals SALL4-induced metabolic vulnerabilities in cancer JL Tan, F Li, JZ Yeo, KJ Yong, MA Bassal, GH Ng, MY Lee, CY Leong, ... Cancer Research 80 (16_Supplement), 1788-1788, 2020 | | 2020 |
| Zinc finger protein SALL4 functions through an AT-rich motif to regulate heterochromatin formation NR Kong, MA Bassal, HK Tan, JV Kurland, KJ Yong, JJ Young, Y Yang, ... bioRxiv, 2020.07. 03.186783, 2020 | | 2020 |
| Targeting SALL4 in lung cancer through a novel Cbl-b/IGF1R&EGFR axis A Li, W Ou, J Fletcher, KJ Yong, H Yang, R Soo, D Tenen, L Chai Cancer Research 74 (19_Supplement), 3389-3389, 2014 | | 2014 |
